Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 11, 2004. The report serves as a notification of a change in director interests rather than a comprehensive financial results announcement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The only financial data present relates to a specific share transaction:
- Share Purchase Price: GBP 10.72 per Ordinary Share.
- Transaction Date: August 10, 2004.
Material Changes
The material change reported is an increase in the shareholding of Director Mr. J D Coombe under the Company's ShareReward Plan. The transaction details are as follows:
- Acquisition Type: Purchase of Ordinary Shares.
- Personal Contribution: Acquisition of 12 Ordinary Shares.
- Company Contribution (Matching): Acquisition of 12 Ordinary Shares.
- Total Shares Acquired: 24 Ordinary Shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly limited to the disclosure of the director's share interest change.
Investor Verification Checklist
- Verify the total number of shares held by Mr. J D Coombe following this transaction.
- Confirm the terms of the ShareReward Plan regarding the matching element.
- Check for any other pending director share transactions not included in this specific filing.